Sleep News and Research

Latest Sleep News and Research

Combination of night work, overtime and shortened sleep can increase risk of stroke and heart disease

A new study published in the current issue of Archives of Environmental & Occupational Health (vol. 64, No. 3) shows that this combination of night work, overtime and shortened sleep can contribute to the development among police officers of the metabolic syndrome, a combination of unhealthful factors that increase the risk of cardiovascular disease (CVD), primarily heart disease and stroke.

18 Nov 2009

CMS policy changes to drive the sleep management devices market

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, policy changes made by the Center for Medicare and Medicaid Services (CMS) will cause a surge in obstructive sleep apnea (OSA) diagnostic testing and treatment. MRG's new US Market Opportunities for Respiratory and Sleep Management Devices 2010 report finds that increasing reimbursement opportunities for OSA diagnosis and treatment will drive the OSA market to $1.5 billion by 2014.

17 Nov 2009

Lack of sleep can lead to devastating errors, says new study

Sleep deprivation adversely affects automatic, accurate responses and can lead to potentially devastating errors, a finding of particular concern among firefighters, police officers, soldiers and others who work in a sleep-deprived state, University of Texas at Austin researchers say.

17 Nov 2009

BioSante Pharmaceuticals applauds Boehringer Ingelheim for developing a therapy to treat HSDD

BioSante Pharmaceuticals, Inc., a specialty pharmaceutical company developing products for female sexual health, including LibiGel® for the treatment of hypoactive sexual desire disorder (HSDD), applauds the efforts of Boehringer Ingelheim to develop a therapy to treat this unmet medical need.

17 Nov 2009

FDA approves NeurogesX's Qutenza patch for postherpetic neuralgia treatment

NeurogesX, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Qutenza(TM) (capsaicin) 8% patch, the first and only product containing prescription strength capsaicin, for the management of neuropathic pain due to postherpetic neuralgia (PHN), the nerve pain which can follow shingles.

17 Nov 2009

Health Mason software to streamline health care claim payment process

With health care reform taking the national spotlight, the sole point of agreement by all parties is that some form of change is necessary. Many health care industry experts believe that now is the worst time for government-mandated change because innovation has already begun to occur organically from within the industry. One Franklin Tennessee-based software company is defining that innovation and garnering attention in the industry.

17 Nov 2009

ECR Pharmaceuticals to commercialize and manufacture ZolpiMist in the U.S. and Canada

NovaDel Pharma Inc. today announced its entry into an exclusive license and distribution agreement with ECR Pharmaceuticals Company, Inc., a wholly owned subsidiary of Hi-Tech Pharmacal Co., Inc. to commercialize and manufacture ZolpiMist™ in the United States and Canada. ZolpiMist™ is our oral spray formulation of zolpidem tartrate approved by the FDA in December of 2008.

16 Nov 2009

Cortex Pharmaceuticals reports a net loss of $0.06 per share for the quarter ended September 30, 2009

Cortex Pharmaceuticals, Inc. reported a net loss applicable to common stock of $3,243,000, or $0.06 per share for the quarter ended September 30, 2009 compared with a net loss applicable to common stock of $3,148,000, or $0.07 per share for the corresponding prior year period.

16 Nov 2009

Positive results from Winston Laboratories' Civamide Patch trial

Winston Laboratories, Inc., a wholly-owned subsidiary of Winston Pharmaceuticals, Inc. today announced positive top-line results from Study WL1001-04-03, a Phase II clinical trial evaluating the safety and efficacy of the company's patch formulation of Civamide, a novel TRPV-1 receptor modulator in the treatment of post-herpetic neuralgia (PHN).

16 Nov 2009

Mayo Clinic Health Letter provides treatment options for people with heart disorders

Fewer than one-third of patients with heart failure are taking the three types of medications that are most effective in prolonging life and improving quality of life. The November issue of Mayo Clinic Health Letter provides an overview of treatments recommended by national guidelines.

16 Nov 2009

Self-care tips for hemorrhoids from Mayo Clinic

By about age 50, more than half of adults have dealt with hemorrhoids. The November issue of Mayo Clinic Health Letter covers home treatments that can relieve symptoms of this common and embarrassing problem.

16 Nov 2009

Orthopedic surgeon specializes in cutting-edge shoulder procedures from a 45-minute technique

Orthopedic surgeon, Dr. Corey G. Solman specializes in cutting-edge shoulder procedures including everything from a 45-minute technique called shoulder resurfacing to a reversed shoulder replacement that relieves pain, restores shoulder function and improves range of motion.

13 Nov 2009

Medtronic launches an educational campaign to raise awareness of overactive bladder

Medtronic, Inc. today announced the kick-off of an educational campaign aimed at raising awareness among women of overactive bladder (OAB), a serious condition that can severely impact patients’ lives. This new campaign, conducted in partnership with leading patient advocacy groups focused on women’s health will help to raise awareness of the prevalence of bladder control problems and encourage patients to find effective treatment options – including and beyond medications.

13 Nov 2009

Transcept Pharmaceuticals reports financial results for the third quarter of 2009

Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in neuroscience, today announced financial results for the three and nine months ended September 30, 2009.

13 Nov 2009

D-Link to showcase its Green networking hardware at the HealthAchieve2009 conference

D-Link has been selected to showcase its environmentally responsible Green networking hardware as part of the Venture Green program in this year's HealthAchieve2009 conference and exhibition on Nov. 16-17 at the Metro Toronto Convention Centre.

12 Nov 2009

Frequent heartburn is painful and impacts the quality of life: Study

While most adults have likely experienced the uncomfortable symptoms of heartburn at least once, for the 50 million American adults who suffer from frequent heartburn two or more days per week, the condition is not only painful, it can also impact their quality of life.

12 Nov 2009

New website on healthy lifestyle and its issues launched by Healthy Life Network

HealthyLifeNetwork.com is officially online and making its healthful presence known on the world-wide web. The new site has been in development for sometime but overall the time to market from concept to publish was fast-tracked by a Chicago-based team of writers, editors, designers and marketing wizards.

12 Nov 2009

Malfunctioning circadian clock genes may be associated with bipolar disorder in children

Malfunctioning circadian clock genes may be responsible for bipolar disorder in children. Researchers writing in the open access journal BMC Psychiatry found four versions of the regulatory gene RORB that were associated with pediatric bipolar disorder.

11 Nov 2009

Veteran peer support is key to combat social isolation and post-traumatic stress disorder

Last month in Washington, Department of Veterans Affairs Secretary Eric Shinseki made a staggering announcement: more veterans have committed suicide since 2001 than have been killed in Iraq and Afghanistan.

11 Nov 2009

Potential benefits of Labopharm's novel trazodone formulation published

Labopharm Inc. today announced an article has been published in the international journal of neuropsychiatric medicine, CNS Spectrums October, 2009 issue, citing the potential benefit of its novel trazodone formulation, which contains Contramid(R). Labopharm's Contramid is the clinically validated proprietary technology that controls the release of active substances from oral medications to optimize drug delivery.

11 Nov 2009

Sleep News and Research

Latest Sleep News and Research

Combination of night work, overtime and shortened sleep can increase risk of stroke and heart disease

CMS policy changes to drive the sleep management devices market

Lack of sleep can lead to devastating errors, says new study

BioSante Pharmaceuticals applauds Boehringer Ingelheim for developing a therapy to treat HSDD

FDA approves NeurogesX's Qutenza patch for postherpetic neuralgia treatment

Health Mason software to streamline health care claim payment process

ECR Pharmaceuticals to commercialize and manufacture ZolpiMist in the U.S. and Canada

Cortex Pharmaceuticals reports a net loss of $0.06 per share for the quarter ended September 30, 2009

Positive results from Winston Laboratories' Civamide Patch trial

Mayo Clinic Health Letter provides treatment options for people with heart disorders

Self-care tips for hemorrhoids from Mayo Clinic

Orthopedic surgeon specializes in cutting-edge shoulder procedures from a 45-minute technique

Medtronic launches an educational campaign to raise awareness of overactive bladder

Transcept Pharmaceuticals reports financial results for the third quarter of 2009

D-Link to showcase its Green networking hardware at the HealthAchieve2009 conference

Frequent heartburn is painful and impacts the quality of life: Study

New website on healthy lifestyle and its issues launched by Healthy Life Network

Malfunctioning circadian clock genes may be associated with bipolar disorder in children

Veteran peer support is key to combat social isolation and post-traumatic stress disorder

Potential benefits of Labopharm's novel trazodone formulation published

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Sleep News and Research

Latest Sleep News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in